Clinical Trial Update: Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating neoadjuvant response-guided treatment for slowly proliferating hormone receptor positive breast tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Snippet

Sponsor: Thomas Hatschek | Conditions: Early-Stage Breast Carcinoma, Hormone Receptor Positive Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING